ITEMS IN AFP WITH KEYWORD:
Jun 15, 2006 Issue
ACIP Updates Recommendations for Immunization Against Hepatitis A Virus [Practice Guidelines]
The Advisory Committee on Immunization Practices (ACIP) has released updated recommendations on the prevention of hepatitis A virus (HAV) infection through immunization; the report also includes new epidemiologic data and results of economic analyses of nationwide routine vaccination of children.
Mar 15, 2006 Issue
CDC Studies the Effectiveness of PCV7 Immunization in Children [Practice Guidelines]
The 7-valent pneumococcal conjugate vaccine (PCV7) was approved in 2000 to prevent pneumococcal disease in children younger than five years. The Centers for Disease Control and Prevention (CDC) has released results from a study evaluating the vaccine’s impact on invasive pneumococcal disease in children since its approval.
Guidelines for the routine use of the newly approved tetravalent meningococcal conjugate vaccine (MCV4) and updated guidelines for the use of the standard tetravalent meningococcal polysaccharide vaccine (MPSV4) have been issued in a policy statement from the Committee on Infectious Diseases of the American Academy of Pediatrics (AAP).
The Centers for Disease Control and Prevention (CDC) has released a report on vaccination coverage in children. The report states that coverage levels are notable given the supply shortage of several vaccines between 2001 and 2004.
The Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP), the American Academy of Family Physicians (AAFP), and the American Academy of Pediatrics (AAP) have released the 2006 recommended immunization schedule for children and adolescents.
Dec 15, 2005 Issue
The 2006 Adult Immunization Schedule: Improving Immunization Rates [Practice Guidelines]
The 2006 Recommended Adult Immunization Schedule provides a concise tool to help family physicians identify who to vaccinate, when to vaccinate, and which vaccine to use.
The Centers for Disease Control and Prevention (CDC) is recommending that caregivers of adolescents who receive quadrivalent meningococcal conjugate vaccine (MCV4; Menactra) be informed of an ongoing investigation into reports of Guillain-Barré syndrome in patients who received the vaccine.
Invasive disease caused by Neisseria meningitidis has an average annual incidence of one case per 100,000 in the United States. The disease can be rapidly fatal or result in severe neurologic and vascular sequelae despite antibiotic therapy. Antibiotic chemoprophylaxis with rifampin, ciprofloxacin, ...
Updated recommendations on the management of meningococcal disease are available from the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC).
A review of interventions to improve influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among high-risk adults younger than 65 years has been issued by the Task Force on Community Preventive Services of the Centers for Disease Control and Prevention (CDC).